Steven L. McCune, MD, PhD is an Atlanta native who joined the cancer care team Northwest Georgia Oncology Centers, P.C. (NGOC) in Marietta upon completion of his Fellowship at Duke University in June 2002. With a special interest in lung cancer, Dr. McCune is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia. He is the Director and Principal Investigator of NGOC’s William S. Gibbons Cancer Research Institute.
“The treatment options for lung cancer are rapidly evolving and expanding. New molecular therapies are allowing us to offer leading-edge, personalized treatments to our patients to improve their outcomes and reduce unnecessary side effects.”
Dr. McCune provides patient-centered cancer care at NGOC’s Marietta Cancer Center.
|Personal Data||Birthplace: Atlanta, GA|
|Undergraduate Education||BS, Biology, June 1987
Massachusetts Institute of Technology
|Medical Education||PhD, Biochemistry
University of Alabama at Birmingham, Medical Scientist Training Program, Department of Biochemistry and Molecular Genetics
Doctor of Medicine
University of Alabama at Birmingham
|Postdoctoral Training||INTERNSHIP and RESIDENCY
University of Alabama at Birmingham, University Hospital
July 1996 - June 1999
Hematology and Medical Oncology
Duke University Medical Center
Durham, North Carolina
July 1999 – June 2002
|Board Certification||American Board of Internal Medicine, Internal Medicine, 2001
American Board of Internal Medicine, Medical Oncology, 2003
American Board of Internal Medicine, Hematology, 2014
|Medical Licensure||State of Georgia, 2001 (Active)|
|Professional Societies||Cobb County Medical Society
Georgia Society of Clinical Oncology
Medical Association of Georgia
|Honors||Third Place Award, Poster Presentation, 1995
Best Graduate Student Publication Award, 1995
First Place Award, Sigma Xi Graduate Student Research Day, 1994
First Place Award, 25th Annual Medical Student Research Day, 1988
|Publications||McCune SL, Gockerman JP, Moore JO, DeCastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA. Alemtuzumab in Relapsed or Refractory CLL and PLL. In Press.
McCune SL, Gockerman JP, Rizzieri DA. Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma. JAMA286: 1149-1152, 2001.
Townes TM, McCune SL. Anti-Sickling Hemoglobin U.S. Patents: 5,864,029 / 5,877,288, 1999.
Chen WY, Bailey EC, McCune SL, Dong J-Y, Townes TM. Reactivation of Silenced, Virally Transduced Genes by Inhibitors of Histone Deacetylase. Proc. Nat. Acad. Sci. USA, 94: 5798-5803,1997.
Townes TM, McCune SL. Transgenic, Cross-Linked Hemoglobin. U.S. Patents: 5,610,137 / 5,849,688, 1997.
Luhovy M, McCune SL, Dong J-Y, Prchal JF, Townes TM, Prchal JT. Stable Transduction of Recomninant Adeno-Associated Virus into Hematopoietic Stem Cells From Normal and Sickle Cell Patients. Biology of Blood and Marrow Transplantation, 2:24-30, 1996.
McCune SL, Reilly M, Chomo M, Asakura T, Townes T. Recombinant Human Hemoglobins Designed for Gene Therapy of Sickle Cell Disease. Proc. Natl. Acad. Sci. USA, 91: 9852-9856, 1994.
McCune SL, Townes TM. Retroviral Vector Sequences Inhibit Human B-Globin Gene Expressions in Transgenic Mice. Nucleic Acids Research, 22: 4477-4481, 1994.
Reilly MP, McCune SL, Ryan TM, Katsumata M, Asakura T. Preparation of Recombinant Hemoglobin in Transgenic Mice. Meth. Enzymol, 231: 403-434, 1994.
Kidd VJ, Luo W, Xiang J, Tu F, Easton J, McCune SL, Snead M. Regulated Expression of a Cell Division Controll-Related Protein Kinase During Development. Cell Growth and Differentiation, 2: 85-93, 1991.
Zinkowski RP, McCune SL, Balczon RD, Rao PN, Brinkley BR. The Centromere and Aneuploidy II: Drug-Induced Detachment and Fragmentation of Kinetochores of Mammalian Chromosomes. Prog. Clin. Biol. Res., 340B: 223-236, 1990.
|Major Research Interests||Clinical Trials (Oncology & Hematology)|